Organization Profile

You just read:

Oncolytics Biotech® Inc. Completes Patient Enrollment in U.S. Phase 2 Study of REOLYSIN® in Non-Small Cell Lung Cancer

News provided by

Oncolytics Biotech Inc.

Mar 05, 2013, 06:30 ET